Drug Trial Radar · NCT00027209
Hormone Replacement in Menopausal Women With Epilepsy
Last checked: Nov 20, 2026Latest source record: May 15, 2006 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
125
Actual
Start
Not stated
Primary completion
Not stated
Sponsor
- Sponsor type
- NIH
- First posted
- Nov 29, 2001
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- Female only, from 0 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this study is to evaluate the effect of synthetic hormone replacement therapy on anti-seizure medication levels, menopausal symptom relief, and seizure frequency and safety in menopausal women with epilepsy.
Conditions
- Menopause
- Epilepsy
Interventions
premproDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
New York Presbyterian Hospital-Weill Medical College of Cornell University, Comprehensive Epilepsy Center
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.